United States

Celerion and Ricerca Biosciences form The Biosimilars Alliance

Thursday, March 1, 2012 11:23 AM

Lincoln, Neb.-based Celerion, a provider of early-stage drug development solutions, and Ricerca Biosciences, which offer discovery, preclinical and development services, have formed “The Biosimilars Alliance,” focused on preclinical and early clinical assessment of biologics manufactured by a new supplier.

More... »

Certara acquires Simcyp, adding preclinical research capability

Thursday, March 1, 2012 11:00 AM

Certara, a provider of drug discovery and development software and scientific consulting services, will acquire U.K-based Simcyp, a research company providing a modeling and simulation platform for predicting the fate of drugs in virtual populations.

More... »

PRI launches OnSite to increase clinical trial enrollment

Thursday, March 1, 2012 10:53 AM

Patient Recruiters International (PRI), a provider of direct patient access solutions for patient recruitment, has launched OnSite.

More... »

Nektar releases positive proof-of-concept data for opioid molecule NKTR-181

Thursday, March 1, 2012 06:02 AM

Nektar Therapeutics has reported positive clinical data for NKTR-181, its new oral opioid analgesic molecule.

More... »

GlaxoSmithKline and Angiochem collaborate on treatments for LSDs

Thursday, March 1, 2012 05:55 AM

Angiochem, a clinical-stage biotechnology company, has partnered with GlaxoSmithKline (GSK) to discover, develop and commercialize treatments for lysosomal storage diseases (LSDs).

More... »

BMS and Duke form strategic relationship

Wednesday, February 29, 2012 02:31 PM

Bristol-Myers Squibb (BMS) and Duke Translational Medicine Institute (DTMI) have formed a strategic relationship to broaden interactions between the two organizations.

More... »

North Shore-LIJ Health System joins Cleveland Clinic’s Innovation Alliance

Tuesday, February 28, 2012 06:11 AM

North Shore-LIJ Health System, the second-largest nonprofit in the U.S. secular healthcare system, has joined Cleveland Clinic’s Innovation Alliance program to enhance the discovery, development, deployment and commercialization of new technologies.

More... »

Peter Bendel and Eran Toledo join Aspect Imaging

Tuesday, February 28, 2012 06:00 AM

Aspect Imaging, a developer of high-performance compact MRI imaging systems, has made two executive appointments:

More... »

Roche extends Illumina tender offer

Monday, February 27, 2012 03:17 PM

Roche has extended its cash tender offer to acquire all outstanding shares of Illumina at $44.50 per share to 6 p.m., Eastern Standard Time, on March 23, 2012.

More... »

Dr. Stephen Chen named chairman, CEO of Amarillo

Monday, February 27, 2012 10:10 AM

Amarillo Biosciences, a U.S. biotechnology firm, has appointed Dr. Stephen T. Chen CEO and chairman of the board.

More... »